Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 238 in total
| Status | Patent |
|---|---|
Application | Utility: ACTIVITY BASED HOST CELL PROTEIN PROFILING Filling date: 5 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: METHODS OF REDUCING POLYSORBATE DEGRADATION IN DRUG FORMULATIONS Filling date: 5 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Anti-IL-33 antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 31 Aug 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR ASSESSING CRISPR/CAS-MEDIATED DISRUPTION OR EXCISION AND CRISPR/CAS-INDUCED RECOMBINATION WITH AN EXOGENOUS DONOR NUCLEIC ACID IN VIVO Filling date: 5 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: CELL CULTURE MEDIUM FOR EUKARYOTIC CELLS Filling date: 5 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES Filling date: 5 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: VEGF Antagonist Formulations Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: FUCOSYLATION-DEFICIENT CELLS Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: VEGF Antagonist Formulations Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: METHODS FOR SCARLESS INTRODUCTION OF TARGETED MODIFICATIONS INTO TARGETING VECTORS Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ANTI-ACVR1 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ANTI-PCSK9 ANTIBODIES Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: STABLE ANTIBODY FORMULATION Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: NON-HUMAN ANIMALS CAPABLE OF DH-DH REARRANGEMENT IN THE IMMUNOGLOBULIN HEAVY CHAIN CODING SEQUENCES Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: Antibodies Comprising Chimeric Constant Domains Filling date: 5 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: Inhibition Of HSD17B13 In The Treatment Of Liver Disease In Patients Expressing The PNPLA3 I148M Variation Filling date: 5 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 5 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: SUPPORT FOR TEST DEVICE Filling date: 5 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: METHODS OF INCREASING STRENGTH AND FUNCTIONALITY WITH GDF8 INHIBITORS Filling date: 5 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: ANTIBODIES, AND BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND HER2 AND/OR APLP2, CONJUGATES, AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: HUMANIZED DIPEPTIDYL-PEPTIDASE IV (DPP4) ANIMALS Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: METHODS FOR WHOLE-CELL GLYCOPROTEOMIC ANALYSIS Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: USE OF LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY TO CHARACTERIZE OLIGONUCLEOTIDES Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Platform for Native Liquid Chromatography-Mass Spectrometry Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: High Confidence Compound Identification by Liquid Chromatography-Mass Spectrometry Filling date: 5 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies Filling date: 5 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED PNPLA3 LOCUS AND METHODS OF USE Filling date: 5 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: Tandem Mass Tag Multiplexed Quantitation of Post-Translational Modifications of Proteins Filling date: 5 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 5 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Microchip capillary electrophoresis assays and reagents Filling date: 5 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Glucagon-like peptide 1 receptor agonists and uses thereof Filling date: 5 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Methods for treating or preventing asthma by administering an IL-4R antagonist Filling date: 5 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Human antibodies to Ebola virus glycoprotein Filling date: 5 Sep 2025 Issue date: 10 Nov 2020 |
Showing 200 to 238 of 238 patents.